Loading, please wait ...


News Analytics

BD5K2CF4GRPRHETPBE3BAELBIU.
REUTERS/Andrew Kelly Sept 20 (Reuters) - The U.S. Food and Drug Administration on Monday approved South Korean drugmaker Samsung Bioepis Co Ltd and Biogen Inc's (BIIB.O) biosimilar rival to Roche Holding AG's (ROG.S) blockbuster eye drug, Lucentis.

Subject Matter

  • Business, economics, society 47.62%
    • Society and people 100.00%
  • Healthcare 26.98%
    • Hospitals, doctors and medical care 100.00%
  • Environment and natural world 25.40%

Emotional Reaction

Sentiment

Positive

Neutral

Negative

Definitions